Trial intelligence / Profile preview

Clofarabine in Acute Leukemias

NCT00098033Phase 2Completed

Start
Sep 2002
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
01

Overview

A Phase 2 trial of clofarabine in acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), chronic myeloid leukemia (CML), myelodysplastic syndrome (MDS). Started Sep 2002; status: completed.

02

Drugs

clofarabine
03

Conditions

acute myeloid leukemia (AML)acute lymphoblastic leukemia (ALL)chronic myeloid leukemia (CML)myelodysplastic syndrome (MDS)

Beyond the preview

Go deeper on NCT00098033.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00098033.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call